Literature DB >> 17950813

Comparison of contrast agent-enhanced versus non-contrast agent-enhanced real-time three-dimensional echocardiography for analysis of left ventricular systolic function.

Boudewijn J Krenning1, Sharon W Kirschbaum, Osama I I Soliman, Attila Nemes, Robert-Jan van Geuns, Wim B Vletter, Caroline E Veltman, Folkert J Ten Cate, Jos R T C Roelandt, Marcel L Geleijnse.   

Abstract

Ultrasound contrast has shown to improve endocardial border definition. The purpose of this study was to evaluate the value of contrast agent-enhanced versus non-contrast agent-enhanced real-time 3-dimensional echocardiography (RT3DE) for the assessment of left ventricular (LV) volumes and ejection fraction. Thirty-nine unselected patients underwent RT3DE with and without SonoVue contrast agent enhancement and magnetic resonance imaging (MRI) on the same day. An image quality index was calculated by grading all 16 individual LV segments on a scale of 0 to 4: 0, not visible; 1, poor; 2, moderate; 3, good; and 4, excellent. The 3-dimensional data sets were analyzed offline using dedicated TomTec analysis software. By manual tracing, LV end-systolic volume, LV end-diastolic volume, and LV ejection fraction were calculated. After contrast agent enhancement, mean image quality index improved from 2.4 +/- 1.0 to 3.0 +/- 0.9 (p <0.001). Contrast agent-enhanced RT3DE measurements showed better correlation with MRI (LV end-diastolic volume, r = 0.97 vs 0.86; LV end-systolic volume, r = 0.96 vs 0.94; LV ejection fraction, r = 0.94 vs 0.81). The limits of agreement (Bland-Altman analysis) showed a similar bias for RT3DE images with and without contrast agent but with smaller limits of agreement for contrast agent-enhanced RT3DE. Also, inter- and intraobserver variabilities decreased. In a subgroup, patients with poor to moderate image quality showed an improvement in agreement after administration of contrast agent (+/-24.4% to +/-12.7%) to the same level as patients with moderate to good image quality without contrast agent (+/-10.4%). In conclusion, contrast agent-enhanced RT3DE is more accurate in assessment of LV function as evidenced by better correlation and narrower limits of agreement compared with MRI, as well as lower intra- and interobserver variabilities.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17950813     DOI: 10.1016/j.amjcard.2007.06.042

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  8 in total

Review 1.  Clinical uses of microbubbles in diagnosis and treatment.

Authors:  David Cosgrove; Chris Harvey
Journal:  Med Biol Eng Comput       Date:  2009-02-10       Impact factor: 2.602

2.  Clinical application of three-dimensional echocardiography: past, present and future.

Authors:  S A Kleijn; O Kamp
Journal:  Neth Heart J       Date:  2009-01       Impact factor: 2.380

3.  Single-beat real-time three-dimensional echocardiographic automated contour detection for quantification of left ventricular volumes and systolic function.

Authors:  Ben Ren; Wim B Vletter; Jackie McGhie; Osama I I Soliman; Marcel L Geleijnse
Journal:  Int J Cardiovasc Imaging       Date:  2013-11-13       Impact factor: 2.357

4.  Current clinical applications of transthoracic three-dimensional echocardiography.

Authors:  Luigi P Badano; Francesca Boccalini; Denisa Muraru; Lucia Dal Bianco; Diletta Peluso; Roberto Bellu; Giacomo Zoppellaro; Sabino Iliceto
Journal:  J Cardiovasc Ultrasound       Date:  2012-03-27

5.  Evaluation of traditional and novel measures of cardiac function to detect anthracycline-induced cardiotoxicity in survivors of childhood cancer.

Authors:  Andrew C Dietz; Shanthi Sivanandam; Suma Konety; Christopher L Kaufman; Ryan M Gage; Aaron S Kelly; Joseph P Neglia; Daniel A Mulrooney
Journal:  J Cancer Surviv       Date:  2013-12-07       Impact factor: 4.442

6.  Three-dimensional echocardiography for left ventricular quantification: fundamental validation and clinical applications.

Authors:  J A van der Heide; S A Kleijn; M F A Aly; J Slikkerveer; O Kamp
Journal:  Neth Heart J       Date:  2011-10       Impact factor: 2.380

7.  Comparison of contrast enhanced three dimensional echocardiography with MIBI gated SPECT for the evaluation of left ventricular function.

Authors:  Bernard Cosyns; David Haberman; Steven Droogmans; Sandrine Warzée; Philippe Mahieu; Eric Laurent; Marie Moonen; Sophie Hernot; Patrizio Lancellotti
Journal:  Cardiovasc Ultrasound       Date:  2009-06-16       Impact factor: 2.062

8.  Potential clinical impact of cardiovascular magnetic resonance assessment of ejection fraction on eligibility for cardioverter defibrillator implantation.

Authors:  Subodh B Joshi; Kim A Connelly; Laura Jimenez-Juan; Mark Hansen; Anish Kirpalani; Paul Dorian; Iqwal Mangat; Abdul Al-Hesayen; Andrew M Crean; Graham A Wright; Andrew T Yan; Howard Leong-Poi
Journal:  J Cardiovasc Magn Reson       Date:  2012-10-08       Impact factor: 5.364

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.